Allogeneic stem cell transplantation is capable of healing a case of bone marrow aplasia following CAR-T cell therapy in a lymphoma patient

Leuk Lymphoma. 2022 Dec;63(12):3012-3014. doi: 10.1080/10428194.2022.2102622. Epub 2022 Jul 22.

Authors

Ginevra Lolli^{1

2}, Margherita Ursi^{1

2}, Michele Dicataldo^{2

3}, Beatrice Casadei^{1

2}, Gianluca Storci³, Lisa Argnani², Francesca Bonifazi³, Pier Luigi Zinzani^{1

2}

Affiliations

¹ IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
² Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
³ IRCCS Azienda-Ospedaliero Universitaria di Bologna, Bologna, Italy.

PMID: 35866874
DOI: 10.1080/10428194.2022.2102622

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Anemia, Aplastic* / pathology
Bone Marrow / pathology
Bone Marrow Transplantation
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Lymphoma* / complications
Lymphoma* / diagnosis
Lymphoma* / therapy
Receptors, Chimeric Antigen*

Substances

Receptors, Chimeric Antigen